Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy

This study is currently recruiting participants.

Verified February 2013 by Peking University

Study NCT01019616 Information provided by Peking University

First Received on November 24, 2009. Last Updated on February 14, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Breast Neoplasms

More general conditions related to this trial

Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases

Interventions listed in this trial

Additional drug interventions recognized in this trial

Adjuvants, Immunologic
Paclitaxel

More general drug interventions related to this trial

Sponsors listed in this trial